MBL Wealth’s PLx Pharma Inc. Common Stock PLXP Stock Holding History

MBL Wealth’s Portfolio PLXP Stock Details PLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-17,300	Closed	-$2.25K	–	187
2023 Q1	$2.25K	Hold	17,300	–	–	﹤0.01%	163
2022 Q4	$3K	Sell	17,300 -8,700	-33%	-$3.64K	﹤0.01%	166
2022 Q3	$17K	Sell	26,000 -26,000	-50%	-$38.3K	﹤0.01%	157
2022 Q2	$126K	Hold	52,000	–	–	0.03%	142
2022 Q1	$210K	Buy	+52,000	New	+$285K	0.05%	160
2021 Q3	$811K	Buy	+42,000	New	+$734K	0.28%	50

Other funds holding PLXP

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 29.84% 1-Year Est. Return

BBA

Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return

MBL Wealth's PLXP Position: Q2 2023 in Review

MBL Wealth sold out of PLx Pharma Inc. Common Stock (PLXP) in Q2 2023, closing a stake of 17,300 shares — an estimated $2.25K sold.

MBL Wealth first reported a position in PLXP in Q3 2021 and held it in 6 quarters. The position peaked at $811K in Q3 2021. 4 funds tracked by Wall St. Rank hold PLXP as of Q2 2023.

MBL Wealth reported no remaining PLx Pharma Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
MBL Wealth sold 17,300 PLx Pharma Inc. Common Stock shares in Q2 2023, an estimated $2.25K.
MBL Wealth first reported a position in PLx Pharma Inc. Common Stock in Q3 2021 and held it in 6 quarters.
MBL Wealth's PLx Pharma Inc. Common Stock position peaked at $811K in Q3 2021.
4 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q2 2023.

Based on MBL Wealth's 13F filing for Q2 2023, filed 17 Jul 2023.